hydrazine has been researched along with Lupus Erythematosus, Systemic in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (53.13) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 1 (3.13) | 29.6817 |
| 2010's | 9 (28.13) | 24.3611 |
| 2020's | 4 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dichtwald, S; Ifrach, N; Meyer, A | 1 |
| Carmi, O; Garra, W; Kivity, S; Levy, Y | 1 |
| Leng, Q; Wang, W; Wang, Y; Wu, L | 1 |
| Carlson, A; Lusa, A | 1 |
| Amoura, Z; Audia, S; Bussel, JB; Chaminade, A; Chauveau, D; Godeau, B; Guitton, Z; Hamidou, M; Hie, M; Lega, JC; Lioger, B; Magy-Bertrand, N; Mahevas, M; Michel, M; Nove-Josserand, R; Rosenthal, E; Terriou, L | 1 |
| Atsumi, T; Kanda, M | 1 |
| Roongta, R; Sanil, S; Shobha, V | 1 |
| Barbosa, LS; Scheinberg, M; Scheinberg, P; Singulane, CC | 1 |
| Cervera, R; Enríquez, H; Espinosa, G; Esteve, J; Magnano, L | 1 |
| Andersen, JC; Dhar, JP; Maroun, MC; Ososki, R | 1 |
| Boulon, C; Constans, J; Vircoulon, M | 1 |
| Cela, I; Katz, RS; Miller, IJ; Rizman, A; Shammo, JM | 1 |
| Frederiksen, H; Gudbrandsdottir, S; Hasselbalch, H | 1 |
| CIOBANU, V; VELICAN, D | 1 |
| Akadegawa, K; Ishikawa, S; Ito, T; Kitabatake, M; Kuriyama, T; Matsushima, K; Sato, T; Suzuki, J; Yurino, H | 1 |
| Reidenberg, MM | 2 |
| De Boccardo, G; Durant, PJ; Harris, RA; Lahita, R; Reidenberg, MM; Stenzel, KH | 1 |
| Iguchi, S; Jimi, S; Kajiyama, K; Kameda, S; Matsuyama, K; Nishigouri, S; Tanaka, K; Yamaguchi, M; Yanase, T | 1 |
| Horai, Y; Iguchi, S; Ishizaki, T; Koya, G; Matsuyama, K | 1 |
| Durant, PJ; Harris, RA | 1 |
| Drayer, DE; Freundlich, B; Lorenzo, B; Reidenberg, MM; Snyder, ES; Stolley, PD; Strom, BL; West, SL | 1 |
| Drayer, DE; Reidenberg, MM | 1 |
| Cassi, E; Massarotti, G; Passaleva, A | 1 |
| Harrison, T; Sisca, TS; Wood, WH | 1 |
| Drózdz, M; Kucharz, EJ; Olczyk, K | 1 |
| Pereyo, N | 1 |
| Chruściel, M | 2 |
| Holtz, G; Martin, H; Schubert, H; Schubert, JC | 1 |
| Deicher, H | 1 |
| Clément, F | 1 |
1 review(s) available for hydrazine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Benzoates; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | 2023 |
31 other study(ies) available for hydrazine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Catastrophic anti-phospholipid syndrome with Libman-Sacks endocarditis following eltrombopag therapy for immune thrombocytopenic purpura: A case report.
Topics: Adult; Antiphospholipid Syndrome; Benzoates; Endocarditis; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles | 2021 |
Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
Topics: Adult; Benzoates; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pyrazoles; Thrombocytopenia; Thrombopoietin | 2021 |
Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.
Topics: Antiphospholipid Syndrome; Autoimmunity; Benzoates; Blood Platelets; Female; Hemorrhage; Humans; Hydrazines; Lupus Erythematosus, Systemic; Middle Aged; Molecular Mimicry; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombin; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Thrombopoietin; Treatment Outcome; Virginia; Young Adult | 2018 |
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.
Topics: Adolescent; Adult; Aged; Antiphospholipid Syndrome; Benzoates; Female; Follow-Up Studies; France; Humans; Hydrazines; Incidence; Lupus Erythematosus, Systemic; Male; Middle Aged; Prognosis; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Thrombopoietin; Thrombosis; Young Adult | 2018 |
Thrombopoietin mimetics for systemic lupus erythematosus with antiphospholipid antibodies should be discussed separately.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Benzoates; Humans; Hydrazines; Lupus Erythematosus, Systemic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombopoietin; Venous Thromboembolism | 2018 |
Eltrombopag: Efficacy and Safety in Steroid Refractory Lupus-Associated Immune Thrombocytopenia.
Topics: Benzoates; Humans; Hydrazines; Lupus Erythematosus, Systemic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Steroids | 2020 |
Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.
Topics: Adult; Benzoates; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Platelet Count; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia; Treatment Outcome | 2014 |
Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
Topics: Adult; Aged; Benzoates; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombopoietin; Treatment Outcome | 2014 |
Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Benzoates; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Retrospective Studies; Thrombopoietin | 2015 |
Eltrombopag in systemic lupus erythematosus with antiphospholipid syndrome: thrombotic events.
Topics: Benzoates; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin | 2016 |
Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE).
Topics: Benzoates; Blood Platelets; Bone Marrow Diseases; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Megakaryocytes; Middle Aged; Molecular Mimicry; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Thrombopoietin; Remission Induction; Treatment Outcome | 2010 |
Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Benzoates; Blood Platelets; Celiac Disease; Denmark; Female; HIV Infections; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Systemic; Male; Middle Aged; Off-Label Use; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recurrence; Retrospective Studies; Thrombocytopenia; Thrombopoietin | 2012 |
[Hydralazine syndrome after prolonged treatment with adelphan].
Topics: Hydralazine; Hydrazines; Hypertension; Lupus Erythematosus, Systemic; Reserpine | 1961 |
Breakdown of mucosal immunity in the gut and resultant systemic sensitization by oral antigens in a murine model for systemic lupus erythematosus.
Topics: Administration, Inhalation; Administration, Oral; Aging; Animals; Antigens; Cell Movement; Crosses, Genetic; Eosinophilia; Escherichia coli Infections; Female; Genetic Predisposition to Disease; Hydrazines; Immune Tolerance; Immunity, Mucosal; Immunoglobulin A; Intestinal Mucosa; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred NZB; Ovalbumin | 2005 |
The chemical induction of systemic lupus erythematosus and lupus-like illnesses.
Topics: Acecainide; Acetylation; Adult; Female; Humans; Hydralazine; Hydrazines; Isoniazid; Lupus Erythematosus, Systemic; Lupus Vulgaris; Lymphocytes; Phenotype; Procainamide; Time Factors | 1981 |
Aromatic amines and the pathogenesis of lupus erythematosus.
Topics: Acecainide; Acetylation; Amines; Anti-Arrhythmia Agents; Humans; Hydrazines; Lupus Erythematosus, Systemic; Male; Middle Aged; Phenotype; Procainamide | 1983 |
Lupus erythematosus-like disease due to hydrazine.
Topics: Adult; Diagnosis, Differential; Diseases in Twins; Female; Humans; Hydrazines; Immunoglobulin G; In Vitro Techniques; Lupus Erythematosus, Systemic; Occupational Diseases; Pedigree; Pokeweed Mitogens; Pregnancy; Twins, Monozygotic | 1983 |
Increased hydrazine excretion associated with systemic lupus erythematosus.
Topics: Acetylation; Adolescent; Adult; Female; Humans; Hydrazines; Isoniazid; Japan; Lupus Erythematosus, Systemic; Male; Middle Aged; Saliva | 1982 |
Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
Topics: Acetylation; Adolescent; Adult; Asian People; Female; Humans; Hydrazines; Isoniazid; Japan; Lupus Erythematosus, Systemic; Male; Middle Aged; Phenotype | 1981 |
Hydrazine and lupus.
Topics: Clinical Laboratory Techniques; Female; Humans; Hydrazines; Laboratories; Lupus Erythematosus, Systemic; Occupational Diseases | 1980 |
Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus.
Topics: Acetylation; Adult; Amines; Dapsone; Environmental Exposure; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Male; Middle Aged; Phenotype; Smoking | 1993 |
Aromatic amines and hydrazines drug acetylation, and lupus erythematodes.
Topics: Acetylation; Amines; Dose-Response Relationship, Drug; Female; Genetic Variation; Humans; Hydrazines; Lupus Erythematosus, Systemic; Phenotype; Time Factors | 1978 |
Lupus-like autoimmune syndrome after levodopa and benserazide.
Topics: Autoimmune Diseases; Benserazide; Humans; Hydrazines; Levodopa; Lupus Erythematosus, Systemic; Male; Middle Aged; Syndrome | 1979 |
Case report. Propranolol-induced lupus syndrome?
Topics: Humans; Hydrazines; Hypertension; Lupus Erythematosus, Systemic; Male; Middle Aged; Practolol; Propranolol; Skin Manifestations | 1976 |
Influence of long-term treatment with hydrazinophthalazines on the activity of lysosomal exoglycosidases in rat tissues.
Topics: Animals; Antibodies, Anti-Idiotypic; Disease Models, Animal; Glycoside Hydrolases; Hydralazine; Hydrazines; Lupus Erythematosus, Systemic; Lysosomes; Male; Organ Specificity; Rats; Rats, Inbred Strains; Reference Values; Todralazine | 1988 |
Hydrazine derivatives and induction of systemic lupus erythematosus.
Topics: Humans; Hydrazines; Lupus Erythematosus, Systemic; Tartrazine | 1986 |
Changes resembling lupus erythematosus after prolonged treatment with Ro-4-4602, a potent inhibitor of 5-HTP-carboxyliase, in white rats.
Topics: 5-Hydroxytryptophan; Aminobenzoates; Animals; Carboxy-Lyases; Cholesterol; Creatinine; Female; Hydrazines; Hydroxyindoleacetic Acid; Kidney; Kynurenine; Liver; Lupus Erythematosus, Systemic; Male; Neutrophils; Proline; Rats; Spleen; Tryptophan; Vanilmandelic Acid | 1969 |
[Immunosuppressive long term therapy of visceral lupus erythematosus].
Topics: Adult; Amides; Antibodies, Antinuclear; Azathioprine; Dactinomycin; Female; Fluorescent Antibody Technique; Humans; Hydrazines; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Middle Aged; Neutrophils; Prednisone; Toluene | 1970 |
[Immunosuppressive therapy in systemic lupus erythematosus].
Topics: Antibodies, Antinuclear; Autoantibodies; Azathioprine; Child; Collagen Diseases; Cyclophosphamide; Evaluation Studies as Topic; Humans; Hydrazines; Immunosuppression Therapy; Lupus Erythematosus, Systemic; Mercaptopurine; Prednisone; Procarbazine | 1972 |
[Symptomatic thrombopenias. Difficulties of early diagnosis and therapeutic possibilities].
Topics: Adult; Blood Platelets; Hemorrhagic Disorders; Hodgkin Disease; Humans; Hydrazines; Immunoelectrophoresis; Lupus Erythematosus, Systemic; Male; Middle Aged; Multiple Myeloma; Prednisone; Purpura; Splenectomy; Thrombocytopenia; Vinblastine; Waldenstrom Macroglobulinemia | 1966 |
Chronic toxicity of carboethoxyphthalazinohydrazine and its influence on the excretion of 5-hydroxyindoleacetic acid and the activity of 5-htp-decarboxylase in white rats.
Topics: Animals; Anura; Aromatic Amino Acid Decarboxylase Inhibitors; Culture Techniques; Dopa Decarboxylase; Female; Heterocyclic Compounds; Hydralazine; Hydrazines; Hydroxyindoleacetic Acid; Kidney; Liver; Lung; Lupus Erythematosus, Systemic; Mice; Rats; Spleen | 1968 |